![Robert Knerr](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Robert Knerr
Former positions of Robert Knerr
Companies | Position | Start | End |
---|---|---|---|
STADA ARZNEIMITTEL | Corporate Officer/Principal | 2010-12-31 | 2021-03-31 |
Haupt Pharma Amareg GmbH
![]() Haupt Pharma Amareg GmbH Pharmaceuticals: MajorHealth Technology Part of Aenova Holding GmbH, Haupt Pharma Amareg GmbH is a German company that manufactures pharmaceutical products. The company is based in Regensburg, Germany. The CEOs of the company are Christian Ewers and Ralf Schuler. | Chief Operating Officer | 2008-03-31 | 2010-11-30 |
Statistics
International
Germany | 3 |
Operational
Corporate Officer/Principal | 1 |
Chief Operating Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
STADA Arzneimittel AG
![]() STADA Arzneimittel AG Pharmaceuticals: MajorHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
Haupt Pharma Amareg GmbH
![]() Haupt Pharma Amareg GmbH Pharmaceuticals: MajorHealth Technology Part of Aenova Holding GmbH, Haupt Pharma Amareg GmbH is a German company that manufactures pharmaceutical products. The company is based in Regensburg, Germany. The CEOs of the company are Christian Ewers and Ralf Schuler. | Health Technology |
- Stock Market
- Insiders
- Robert Knerr
- Experience